FBN1 and triple-A syndrome: Nonetheless, the fact that this association is not seen with AAA even though AAA cases are also prescribed beta-blockers at a higher rate than their respective controls (24.1% versus 12.8%; S7 Table), suggests some biological basis and warrants further investigation, particularly for those with FBN variants.